Rexgenero

Rexgenero is a leading regenerative medicine company and a developer of advanced cell therapies for the treatment of serious diseases that are poorly addressed by existing therapies. They are conducting clinical trials of cell therapies with the aim of obtaining marketing authorization in Europe, the United States, and other markets. Their treatments draw on a unique understanding of the fundamental science behind cell therapy. Their current cell therapy was developed by the Andalusian Health Service (Servicio Andaluz de Salud) and the Andalusian Initiative for Advanced Therapies, and their goal is to collaborate with them to develop further cell therapies to treat other indications with significant unmet medical needs.